Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now by Rana R. McKay

Get full text

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database by Andre P. Fay, Rana R. McKay, Xun Lin, Ronit Simantov, Toni K. Choueiri

Get full text

The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma by Priyanka Naik, Harshitha Dudipala, Yu-Wei Chen, Brent Rose, Aditya Bagrodia, Rana R. McKay

Get full text

The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers by Ava Saidian, Isabella Dolendo, Andrew Sharabi, Tyler F. Stewart, Brent Rose, Rana R. McKay, Aditya Bagrodia, Amirali Salmasi

Get full text

Therapies in Refractory Metastatic Renal Cell Carcinoma by Stephanie Berg, Martin Angel, Kathryn E. Beckermann, Frede Donskov, Chung-Han Lee, Pavlos Msaouel, Rana R. McKay, Tian Zhang

Get full text

SMART COVID Navigator, a Clinical Decision Support Tool for COVID-19 Treatment: Design and Development Study by Varun Suraj, Catherine Del Vecchio Fitz, Laura B Kleiman, Suresh K Bhavnani, Chinmay Jani, Surbhi Shah, Rana R McKay, Jeremy Warner, Gil Alterovitz

Get full text

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer by Joe M. O’Sullivan, Rana R. McKay, Kambiz Rahbar, Karim Fizazi, Daniel J. George, Bertrand Tombal, Anja Schmall, Per Sandström, Frank Verholen, Neal Shore

Get full text

Trends of kidney cancer burden from 1990 to 2019 in European Union 15 + countries and World Health Organization regions by Chinmay Jani, Nour Abdallah, Christian Mouchati, Ruchi Jani, Rajesh Sharma, Padmanabh Bhatt, Georgina Hanbury, Justin Salciccioli, Harpreet Singh, Joseph Shalhoub, Rana R. McKay, Dominic C. Marshall

Get full text

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans by Abhishek Kumar, Daniel R. Cherry, Patrick T. Courtney, Vinit Nalawade, Nikhil Kotha, Paul J. Riviere, Jason Efstathiou, Rana R. McKay, A. Karim Kader, Brent S. Rose, Tyler F. Stewart

Get full text

<i>BRCA1/2</i> Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents by Sourat Darabi, David R. Braxton, Joanne Xiu, Benedito A. Carneiro, Jeff Swensen, Emmanuel S. Antonarakis, Stephen V. Liu, Rana R. McKay, David Spetzler, Wafik S. El-Deiry, Michael J. Demeure

Get full text

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy by Eugene B. Cone, Lorine Haeuser, Stephen W. Reese, Maya Marchese, David-Dan Nguyen, Junaid Nabi, Wesley H. Chou, Joachim Noldus, Rana R. McKay, Kerry Laing Kilbridge, Quoc-Dien Trinh

Get full text

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy. by Eugene B Cone, Lorine Haeuser, Stephen W Reese, Maya Marchese, David-Dan Nguyen, Junaid Nabi, Wesley H Chou, Joachim Noldus, Rana R McKay, Kerry Laing Kilbridge, Quoc-Dien Trinh

Get full text

Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance by Michael V. Sherer, Austin J. Leonard, Tyler J. Nelson, P. Travis Courtney, Kripa Guram, Gustavo Rodrigues De Moraes, Juan Javier-Desloges, Christopher Kane, Rana R. McKay, Brent S. Rose, Aditya Bagrodia

Get full text

Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma by Margaret Meagher, Harris Krause, Andrew Elliott, Alex Farrell, Emmanuel S. Antonarakis, Bruno Bastos, Elisabeth I. Heath, Christina Jamieson, Tyler F. Stewart, Aditya Bagrodia, Chadi Nabhan, Matt Oberley, Rana R. McKay, Amirali Salmasi

Get full text

Impact of age on treatment response in men with prostate cancer treated with radiotherapy by Alex K. Bryant, Tyler J. Nelson, Rana R. McKay, A. Karim Kader, J. Kellogg Parsons, John P. Einck, Christopher J. Kane, Ajay P. Sandhu, Arno J. Mundt, James D. Murphy, Brent S. Rose

Get full text

Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation by Nikhil V. Kotha, BS, Abhishek Kumar, MD, MAS, Tyler J. Nelson, BS, Edmund M. Qiao, BS, Alex S. Qian, BS, Rohith S. Voora, BS, Rana R. McKay, MD, Tyler F. Stewart, MD, Brent S. Rose, MD

Get full text

The Genomic Landscape of Urothelial Carcinoma with High and Low <i>ERBB2</i> Expression by Agreen Hadadi, Harris B. Krause, Andrew Elliott, Jacqueline T. Brown, Bassel Nazha, Lara R. Harik, Bradley C. Carthon, Benjamin Miron, Chadi Nabhan, Pedro C. Barata, Mohamed Saleh, Yuanquan Yang, Rana R. McKay, Mehmet A. Bilen

Get full text

Analysis of CDK12 alterations in a pan‐cancer database by Elizabeth Pan, Angelo Cabal, Juan Javier‐DesLoges, Devin Patel, Justine Panian, Suzanna Lee, Justin Shaya, Taylor Nonato, Xiaojun Xu, Tyler Stewart, Brent Rose, Ahmed Shabaik, Ezra Cohen, Razelle Kurzrock, Pablo Tamayo, Rana R. McKay

Get full text

Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts by Dominick Bossé, Wanling Xie, Xun Lin, Ronit Simantov, Aly-Khan A. Lalani, Jeffrey Graham, J. Connor Wells, Frede Donskov, Brian Rini, Benoit Beuselinck, Ajjai Alva, Aaron Hansen, Lori Wood, Denis Soulières, Christian Kollmannsberger, Francois Patenaude, Daniel Y.C. Heng, Toni K. Choueiri, Rana R. McKay

Get full text

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study by Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta, Michael E. Hahn, Pradip De, Casey Williams, Jessica Guido, Benjamin M. Solomon, Rana R. McKay, Amy Krie, Sarah G. Boles, Jeffrey S. Ross, J. Jack Lee, Brian Leyland-Jones, Scott M. Lippman, Razelle Kurzrock

Get full text